Literature DB >> 25658695

Statin use and cognitive function: population-based observational study with long-term follow-up.

Hanneke Joosten, Sipke T Visser, Marlise E van Eersel, Ron T Gansevoort, Henk J G Bilo, Joris P Slaets, Gerbrand J Izaks.   

Abstract

We aimed to evaluate the association between statin use and cognitive function. Cognitive function was measured with the Ruff Figural Fluency Test (RFFT; worst score, 0; best score, 175 points) and the Visual Association Test (VAT; low performance, 0-10; high performance, 11-12 points) in an observational study that included 4,095 community-dwelling participants aged 35-82 years. Data on statin use were obtained from a computerized pharmacy database. Analysis were done for the total cohort and subsamples matched on cardiovascular risk (N = 1232) or propensity score for statin use (N = 3609). We found that a total of 904 participants (10%) used a statin. Statin users were older than non-users: mean age (SD) 61 (10) vs. 52 (11) years (p < 0.001). The median duration of statin use was 3.8 (interquartile range, 1.6-4.5) years. Unadjusted, statin users had worse cognitive performance than non-users. The mean RFFT score (SD) in statin users and non-users was 58 (23) and 72 (26) points, respectively (p < 0.001). VAT performance was high in 261 (29%) statin users and 1351 (43%) non-users (p < 0.001). However, multiple regression analysis did not show a significant association of RFFT score with statin use (B, -0.82; 95%CI, -2.77 to 1.14; p = 0.41) nor with statin solubility, statin dose or duration of statin use. Statin users with high doses or long-term use had similar cognitive performance as non-users. This was found in persons with low as well as high cardiovascular risk, and in younger as well as older subjects. Also, the mean RFFT score per quintile of propensity score for statin use was comparable for statin users and non-users. Similar results were found for the VAT score as outcome measure. In conclusion, statin use was not associated with cognitive function. This was independent of statin dose or duration of statin use.

Entities:  

Year:  2015        PMID: 25658695      PMCID: PMC4319950          DOI: 10.1371/journal.pone.0118045

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Notice of Republication

This article was republished on January 2, 2015, to replace incorrect figures. The publisher apologizes for the error. Please download the article again to view the correct version.
  1 in total

1.  Statin use and cognitive function: population-based observational study with long-term follow-up.

Authors:  Hanneke Joosten; Sipke T Visser; Marlise E van Eersel; Ron T Gansevoort; Henk J G Bilo; Joris P Slaets; Gerbrand J Izaks
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

  1 in total
  1 in total

1.  Pharmacological treatment of increased vascular risk and cognitive performance in middle-aged and old persons: six-year observational longitudinal study.

Authors:  Marlise E A van Eersel; Sipke T Visser; Hanneke Joosten; Ron T Gansevoort; Joris P J Slaets; Gerbrand J Izaks
Journal:  BMC Neurol       Date:  2020-06-12       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.